| Irritable bowel syndrome; update on pathophysiology and management | Eamonn QUIGLEY,Orla F. CRIG | 313–322 |
| Prevalence and demographic determinants of gastroesophageal reflux disease (GERD) in the Turkish general population: A population-based cross-sectional study | Zeynel MUNGAN | 323–332 |
| A study on the protective activity of kefir against gastric ulcer | Yahya T. ORHAN,CEM KARAGÖZLÜ,Sülen SARIOĞLU,Osman YILMAZ,Nergiz MURAT,SEDEF GİDENER | 333–338 |
| Increased anti-Echinococcus granulosus antibody positivity in Fasciola hepatica infection | Muhsin KAYA,Remzi BEŞTAŞ,Sadullah GİRGİN,Muttalip ÇİÇEK,Mehmet Ali KAPLAN | 339–343 |
| Bone marrow mononuclear cell transplant therapy in mice with CCl4-induced acute liver failure | Jin SHIZHU,Meng XIANGWEI,Sun XUN,Han MINGZI,Liu BINGRONG,Kong DEXIA,Wang XINGHONG,Pei FENGHUA | 344–352 |
| AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B | FATİH GÜZELBULUT,Mesut SEZİKLİ,Züleyha ÇETİNKAYA AKKAN,BÜLENT YAŞAR,Selvinaz ÖZKARA,Oya ÖVÜNÇ KURDAŞ | 353–358 |
| Sclerotherapy of simple hepatic cysts by repeated aspiration and alcohol instillation | Feng YAN-HONG,Qian LIN-XUE,Gong HAI-MA,Zhang QING,Gui YU,Hu XIANGDONG | 359–365 |
| Documented 2009 H1N1 influenza A infection in pediatric liver transplant patients Description and follow-up of 7 patients | MUSTAFA SERDAR CANTEZ,Nelgin GERENLİ,Selda TÖRÜN HANÇERLİ,AYPER SOMER,Nuran SALMAN,ÖZLEM DURMAZ | 366–370 |
| Early repeat endoscopic retrograde cholangiopancreatography: Predictive factors and interventions required | Erkan PARLAK,Cem CENGİZ,SELÇUK DİŞİBEYAZ,Bahattin ÇİÇEK,Yasemin ÖZİN,SABİTE KACAR,Nurgül ŞAŞMAZ,Burhan ŞAHİN | 371–377 |
| Spontaneous remission of sclerosing mesenteritis | Mustafa HASBAHÇECİ,Fatih BAŞAK,MEHMET ŞEKER,Tolga CANBAK,Ali KILIÇ,ORHAN ALİMOĞLU | 378–380 |
| Small bowel leiomyosarcoma: A case report and literature review | Rob ARTS,Koop BOSSCHA,Erik RANSCHAERT,Jeroen VOGELAAR |